What is Century Therapeutics, Inc. Common Stock's Market Cap?

Century Therapeutics, Inc. Common Stock's Market Cap is $374.8M, based on as-reported figures from SEC (XBRL) filings.

What is Century Therapeutics, Inc. Common Stock's Price / Sales?

Century Therapeutics, Inc. Common Stock's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.

What is Century Therapeutics, Inc. Common Stock's Revenue (TTM)?

Century Therapeutics, Inc. Common Stock's Revenue (TTM) is $109.2M, based on as-reported figures from SEC (XBRL) filings.

What is Century Therapeutics, Inc. Common Stock's Net Income (TTM)?

Century Therapeutics, Inc. Common Stock's Net Income (TTM) is -$109.8M, based on as-reported figures from SEC (XBRL) filings.

What is Century Therapeutics, Inc. Common Stock's EBITDA?

Century Therapeutics, Inc. Common Stock's EBITDA is -$104.7M, based on as-reported figures from SEC (XBRL) filings.

What is Century Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Century Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.61, based on as-reported figures from SEC (XBRL) filings.

What is Century Therapeutics, Inc. Common Stock's EBITDA Margin?

Century Therapeutics, Inc. Common Stock's EBITDA Margin is -95.9%, based on as-reported figures from SEC (XBRL) filings.

Century Therapeutics, Inc. Common Stock (IPSC) Financial Statements

Century Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00PM8N5Y8

XNAS · usd

2.07▼ 0.04 (-1.90%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close2.11

Day's Range2.03 – 2.13

52-Week Range0.44 – 3.04

Volume226.9K

Avg Volume500.6K

Share Statistics

Shares Outstanding

Employees78

ExchangeXNAS

Listed2021-06-18

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Century Therapeutics, Inc. Common Stock (IPSC)

What is Century Therapeutics, Inc. Common Stock's Market Cap?: Century Therapeutics, Inc. Common Stock's Market Cap is $374.8M, based on as-reported figures from SEC (XBRL) filings.
What is Century Therapeutics, Inc. Common Stock's Price / Sales?: Century Therapeutics, Inc. Common Stock's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Century Therapeutics, Inc. Common Stock's Revenue (TTM)?: Century Therapeutics, Inc. Common Stock's Revenue (TTM) is $109.2M, based on as-reported figures from SEC (XBRL) filings.
What is Century Therapeutics, Inc. Common Stock's Net Income (TTM)?: Century Therapeutics, Inc. Common Stock's Net Income (TTM) is -$109.8M, based on as-reported figures from SEC (XBRL) filings.
What is Century Therapeutics, Inc. Common Stock's EBITDA?: Century Therapeutics, Inc. Common Stock's EBITDA is -$104.7M, based on as-reported figures from SEC (XBRL) filings.
What is Century Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Century Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.61, based on as-reported figures from SEC (XBRL) filings.
What is Century Therapeutics, Inc. Common Stock's EBITDA Margin?: Century Therapeutics, Inc. Common Stock's EBITDA Margin is -95.9%, based on as-reported figures from SEC (XBRL) filings.